Answers are grounded in this paper and cite their sources.
Background: Keratoacanthoma (KA) is a rapidly growing, well-differentiated squamous neoplasm that is generally considered a variant of squamous cell carcinoma (SCC). Although surgical excision remains the standard of care, nonsurgical treatment options may be desirable in selected patients. Red-light photodynamic therapy (PDT) with 10% aminolevulinic acid (ALA) gel is an established treatment for actinic keratoses and has demonstrated efficacy in superficial nonmelanoma skin cancers. This prospective pilot study evaluated red-light PDT with 10% ALA gel for the treatment of keratoacanthoma. Methods: Five subjects with biopsy-confirmed KA or well-differentiated SCC measuring 0.5–1.5 cm on the trunk or extremities were enrolled. Lesions were debrided, treated with 10% ALA gel, and incubated under occlusion for 2.5 hours before red-light illumination. Subjects received two PDT treatments two weeks apart; one subject received a third treatment as clinically indicated. Clinical response was assessed 3 months after the final PDT treatment using a lesion score of 0–2, with 0 indicating no clinical evidence of remaining tumor. Tolerability during treatment was evaluated using a 10-point visual analog scale (VAS), and recurrence was assessed at the 3-month follow-up. Results: All five subjects demonstrated complete clinical resolution at the 3-month follow-up, with lesion scores of 0, and no clinical recurrences were documented. Mean patient-reported pain scores were 3.3 during PDT #1 and 3.1 during PDT #2; the subject who underwent a third treatment reported a VAS score of 7.0. Lesion size progressively decreased across treatment visits, with complete clinical clearance maintained at 3 months. Conclusion: In this prospective pilot study, red-light PDT with 10% ALA gel resulted in complete clinical resolution of KA in all five subjects, with no clinical recurrence observed at 3-month follow-up. Treatment was generally well tolerated during illumination. These preliminary findings suggest that red-light PDT with 10% ALA gel may represent a nonsurgical treatment option for selected keratoacanthomas. Larger prospective studies with longer follow-up are warranted to further characterize efficacy, recurrence rates, and durability of response. Support this Investigator-Initiated study was provided by Biofrontera Inc
No takes yet. Share an insight, caveat, or question.
Cizenski et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: